The bipolar needle-knife (B-knife) was originally developed by Doi et al in collaboration with the Zeon Medical Company (Tokyo, Japan) in 2002. The main advantage of the B-knife is safety. The electric current is limited to the needle, and the highest density of current stays near the sheath pole. The risks of both perforation and coagulation effect to the muscle layer are, therefore, significantly reduced.1,2 Several clinical studies have demonstrated the safety of the B-knife.3,4